Social & Media

Home / Social & Media / CLINUVEL in the News

CLINUVEL in the News

To receive regular updates, including all of CLINUVEL’s announcements, you can subscribe to our email database here.

A selection of press coverage is listed below:

Clinuvel Pharmaceuticals CEO speaks about the company’s focus on treating a range of severe skin disorders
FDA approves drug for rare condition that triggers intense pain from light exposure
FDA approves Clinuvel’s rare genetic disorder treatment
Thomson Reuters
Philippe Wolgen of CLINUVEL PHARMACEUTICALS driven by competition
The Australian
New Treatment Inspires Hope for the Battle Against Sun Allergy
Good Morning America
Drug Offers Hope Against Disease Where Sunlight Causes Pain
Health Day
Implanted drug improves tolerance of sunlight in rare condition
11-Year-Old ‘Allergic’ to Sunlight
Good Morning America
Out of the shadows (content only available in the USA)
NBC Dateline
Wanneer de zon een hel wordt
VTM News
CLINUVEL To Build Vitiligo Pipeline And Commercial Presence
The Pink Sheet
CLINUVEL’s subisidiary develops drug candidate for vitiligo
Biospectrum Asia
Sonne im Herzen
SRF Aescherbach
INTERVIEW: CLINUVEL’s Philippe Wolgen on Scenesse and the patient factor
Interview – CLINUVEL scores at last, courtesy of patient lobby
EP Vantage
Exposure to sunlight burns my skin – now I can come out the shadows thanks to new drug
Bournemouth Echo
CLINUVEL’s tanning agent nears approval for porphyria
Nature Biotech
Aus dem Schatten hervortreten